Literature DB >> 22246735

Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.

Shuxia Zhou1, Brad Evans, Christian Schöneich, Satish K Singh.   

Abstract

Trace amounts of metals are inevitably present in biotherapeutic products. They can arise from various sources. The impact of common formulation factors such as protein concentration, antioxidant, metal chelator concentration and type, surfactant, pH, and contact time with stainless steel on metal leachables was investigated by a design of experiments approach. Three major metal leachables, iron, chromium, and nickel were monitored by inductively coupled plasma-mass spectrometry. It was observed that among all the tested factors, contact time, metal chelator concentration, and protein concentration were statistically significant factors with higher temperature resulting in higher levels of leached metals. Within a pH range of 5.5-6.5, solution pH played a minor role for chromium leaching at 25°C. No statistically significant difference was observed due to type of chelator, presence of antioxidant, or surfactant. In order to optimize a biotherapeutic formulation to achieve a target drug product shelf life with acceptable quality, each formulation component must be evaluated for its impact.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246735      PMCID: PMC3299453          DOI: 10.1208/s12249-011-9747-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  19 in total

Review 1.  Formulation and delivery issues for monoclonal antibody therapeutics.

Authors:  Ann L Daugherty; Randall J Mrsny
Journal:  Adv Drug Deliv Rev       Date:  2006-05-22       Impact factor: 15.470

Review 2.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

3.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

Review 4.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.

Authors:  J L Cleland; M F Powell; S J Shire
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1993       Impact factor: 4.889

5.  Precipitation of a monoclonal antibody by soluble tungsten.

Authors:  Jared S Bee; Stephanie A Nelson; Erwin Freund; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

6.  Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118.

Authors:  K Uchida; S Kawakishi
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

7.  Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation.

Authors:  S Li; T H Nguyen; C Schöneich; R T Borchardt
Journal:  Biochemistry       Date:  1995-05-02       Impact factor: 3.162

8.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

9.  Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate.

Authors:  G Marx; M Chevion
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

10.  Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.

Authors:  Parag Kolhe; Elizabeth Amend; Satish K Singh
Journal:  Biotechnol Prog       Date:  2010 May-Jun
View more
  2 in total

1.  Fluorogenic tagging methodology applied to characterize oxidized tyrosine and phenylalanine in an immunoglobulin monoclonal antibody.

Authors:  Shuxia Zhou; Olivier Mozziconacci; Bruce A Kerwin; Christian Schöneich
Journal:  Pharm Res       Date:  2013-02-15       Impact factor: 4.200

2.  Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies.

Authors:  Shrenik Mehta; Heather Flores; Benjamin Walters; Alavattam Sreedhara
Journal:  Pharm Res       Date:  2021-08-11       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.